Ideas to Action:

Independent research for global prosperity

Multimedia

CGD's weekly Global Prosperity Wonkcast, event videos, whiteboard talks, slides, and more.

Making Markets for Vaccines

11/17/11

Johnny West
In this two-minute 2006 video clip, Ruth Levine, then CGD senior fellow and director for global health, tells the story of CGD’s Making Markets for Vaccines initiative. She describes how a CGD Working Group produced an economic and legal framework for funds to incentivize vaccine development. The G-7 Finance Ministers endorsed the approach and five donors (Canada, Italy, Norway, UK and Russia, and the Gates Foundation) committed $1.5 billion to create an incentive for a vaccine against the strains of pneumococcus disease prevalent in low-income countries. Owen Barder, a co-author of the working group report, and Alice Albright, a member of the working group who was then CFO of the Global Alliance for Vaccines and Immunization, help tell the story of moving this innovative proposal from idea to action.

 

Monitoring the Billions Spent for HIV/AIDS

11/8/11

Johnny West

Funding for HIV/AIDS has increased massively in the past few years. But is the money being used in the best possible way? In this short clip, CGD experts Nandini Oomman and Mead Over describe the HIV/AIDS monitor initiative which analyzes how PEPFAR, The Global Fund, and the World Bank deliver aid. The initiative has pushed for greater information disclosure and has made an impact on HIV/AIDS aid effectiveness.

Safer, Faster, Cheaper: Improving Clinical Trials and Regulatory Pathways to Fight Neglected Diseases (Event Video)

11/2/11

Pak Report

An estimated one billion people suffer from one or more neglected diseases like Tuberculosis, Malaria, Dengue Fever or others, and hundreds of millions of dollars have been spent to find effective treatments. Medicines, therapies and treatments have been discovered, but regulatory barriers in the late-stage clinical trials of developing countries have prevented these drugs from helping those in need.

Turning the Tide in the War on Tobacco: Bill Savedoff

8/15/11

Most people understand the personal risks associated with smoking, but surprisingly few understand its impact globally. Every year, more people die form tobacco related illnesses than from HIV/Aids, TB and malaria combined. Nevertheless, governments and international aid agencies have yet ot pay serious attention to what some believe to be one of hte most needless disease burdens in human history.

Here to breathe some fresh air into the fight to curb smoking is senior fellow Bill Savedoff, who joins me this week to discuss his latest blog post, Death by Tobacco: A Big Problem Needs Bigger Action. Upon returning from a meeting on tobacco control in New York City last month. Bill set out to raise the alarm about something he found to be shockingly little-known: the shockingly low cost of highly effective tobacco controls.

Worms at Work: Long-run Impacts of Child Deworming in Kenya (Event)

5/27/11

Gilbert Burnham

The Center for Global Development is proud to have hosted Prof. Michael Kremer (Harvard) and Sarah Baird (GWU) as part of the Massachusetts Avenue Development Seminar (MADS) series.  They presented the long-term, follow-up results of Prof. Kremer's research on deworming in Kenyan schools that shows significant, long-term gains in employment and earnings among dewormed children.

Innovation in Vaccine Financing: Assessing Progress and Envisioning Future Directions (Event Video)

4/8/11

Alice Albright

In a recent speech, USAID Administrator Rajiv Shah said “The evidence is clear: vaccines are the best public health investment we can make.” As the Global Alliance for Vaccines and Immunization (GAVI) prepares for its June 2011 pledging conference, CGD hosted a panel to look back at global efforts to support vaccination funding in developing countries over the past decade and reflect on lessons learned and future potential. The panel also looked to the issues and challenges facing vaccination financing in the 2010s.

Confronting the Global Tobacco Epidemic: Thomas Bollyky

2/7/11

Tom BollykyTen years after President Clinton's initiative to avert a global epidemic of tobacco-related disease, smoking is down in the United States but rising fast in poor countries, where Washington turns a blind eye to aggressive cigarette marketing banned at home.

My guest on this show is Thomas Bollyky, a visiting fellow here at CGD. Tom recently marked the 10th anniversary of Clinton’s order with articles in Foreign Policy and the Journal of the American Medical Association about how U.S. efforts to combat the global tobacco epidemic have remained modest, while tobacco companies have aggressively expanded markets for their products and opposed tobacco control and prevention programs in low- and middle-income countries.

Rationing Health Care the NICE Way (Event Video)

1/14/11

CGD is pleased to host Sir Andrew Dillon, chief executive of the UK National Institute for Health and Clinical Excellence (NICE), and Dr. Kalipso Chalkidou, Director of NICE International, to discuss the relevance of institutions such as NICE to improving value for money in health and the characteristics, strengths and limitations of current institutions in the developed and developing world.

The Year Ahead in Global Health at CGD: Amanda Glassman

1/4/11

Amanda GlassmanTo mark the start of the new year, my guest is Amanda Glassman, CGD’s new director of global health. I asked Amanda, who previously worked at the Inter-American Development Bank, the Brookings Institution, and USAID, where she sees opportunities for progress on global health in 2011 and beyond.

Amanda summarizes her priorities for CGD’s global health program with two big questions. First, how can donors deploy their global health aid budgets (more constrained than ever) to have the greatest impact on health in poor countries? Second, how can these same donors help poor countries and poor people use their own resources more effectively?

Type

Topics

Expert

Initiative

Date